Dealert› Deals› Precision Science

Pivotal Group → Precision Science

Buyout United States of America Biotechnology & Medical Research (NEC) Other / Unspecified
Deal summary

Information on the target

The target company, Precision Science, is a prominent player in the animal health sector, specializing in contract manufacturing services for veterinary products. With a strong reputation for quality and compliance, Precision Science has established itself as a trusted partner for various stakeholders in the animal health industry. The company has demonstrated significant growth potential, driven by increasing demand for innovative veterinary solutions and a robust pipeline of products in development.

Founded with a commitment to advancing animal health, Precision Science has built a diverse portfolio that includes a range of veterinary pharmaceuticals and biologics. The company’s state-of-the-art manufacturing facilities are equipped to meet stringent regulatory standards, ensuring the delivery of safe and effective products to its clients.

Industry overview in the target’s specific country

The Biotechnology & Medical Research (NEC) industry in the United States is experiencing a transformative phase, characterized by rapid advancements in technology and increasing investment in research and development. The sector is pivotal in addressing the growing demand for innovative healthcare solutions, particularly in the veterinary field. As pet ownership continues to rise, the need for effective animal health products has become more pronounced, driving growth within this niche market.

In recent years, the U.S. has seen a surge in biotechnology firms focusing on animal health, with many companies leveraging cutting-edge research to develop novel therapies and diagnostics. This trend is supported by favorable regulatory frameworks that encourage innovation while ensuring safety and efficacy. The collaboration between academia and industry has also fostered a vibrant ecosystem, enabling the rapid translation of scientific discoveries into market-ready products.

Moreover, the COVID-19 pandemic has accelerated the adoption of digital health solutions in the veterinary space, with telehealth services gaining traction among pet owners. This shift is reshaping the landscape of veterinary care, prompting companies to invest in technology-driven solutions that enhance service delivery and patient outcomes. As a result, the Biotechnology & Medical Research (NEC) industry is poised for sustained growth, driven by a combination of technological advancements and evolving consumer preferences.

The rationale behind the deal The acquisition of Precision Science by Pivotal Group represents a strategic move to capitalize on the burgeoning demand for animal health products. By integrating Precision Science's manufacturing capabilities with Pivotal Group's extensive network and resources…

This is a public preview. The full deal page — disclosed financials, full description, advisers, comparable set — is available with a free account.
Create free account
View primary source ↗